Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Drug-drug Interaction Study Between Orally Administered Rifampicin and Vilaprisan [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the drug-drug interaction between rifampicin and vilaprisan in endometriosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rifampicin
  • Vilaprisan (vilaprisan)

Snippet

Sponsor: Bayer | Conditions: Endometriosis | Phase 1 | Status: COMPLETED